Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) Return on Equity (2016 - 2017)

Tenax Therapeutics' Return on Equity history spans 5 years, with the latest figure at 4.83% for Q3 2017.

  • For Q3 2017, Return on Equity fell 452.0% year-over-year to 4.83%; the TTM value through Sep 2017 reached 4.83%, down 452.0%, while the annual FY2016 figure was 1.02%, N/A changed from the prior year.
  • Return on Equity for Q3 2017 was 4.83% at Tenax Therapeutics, down from 4.54% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.3% in Q3 2016 and bottomed at 23.7% in Q1 2013.
  • The 3-year median for Return on Equity is 4.35% (2017), against an average of 6.65%.
  • The largest YoY upside for Return on Equity was -452bps in 2017 against a maximum downside of -452bps in 2017.
  • A 3-year view of Return on Equity shows it stood at 23.7% in 2013, then surged by 90bps to 2.33% in 2016, then tumbled by -107bps to 4.83% in 2017.
  • Per Business Quant, the three most recent readings for TENX's Return on Equity are 4.83% (Q3 2017), 4.54% (Q2 2017), and 4.17% (Q1 2017).